Also trades as: 0J9P.L (LSE) · $vol 0M
INCY NASDAQ
Incyte Corporation
1W: -0.2%
1M: +0.7%
3M: -3.9%
YTD: -4.0%
1Y: +49.2%
3Y: +50.6%
5Y: +17.9%
$97.16
-0.25 (-0.26%)
Weekly Expected Move ±3.7%
$88
$92
$95
$99
$102
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
Articles (1)
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (100)
Here's Why Incyte (INCY) is a Strong Value Stock
Why Incyte (INCY) is a Top Growth Stock for the Long-Term
Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View Raised
Why Incyte (INCY) is a Top Value Stock for the Long-Term
Here's Why Incyte (INCY) is a Strong Growth Stock
Why Incyte (INCY) is a Top Momentum Stock for the Long-Term
Healthcare earnings impress with 86% beat rate, yet sector lags: Earnings Scorecard
Company News for Apr 29, 2026
Incyte outlines $4.77B-$4.94B 2026 net sales while preparing four launches over 12 months
Incyte (INCY) Q1 2026 Earnings Call Transcript
Incyte (INCY) Q2 2025 Earnings Transcript
INCY Q1 Earnings and Revenues Beat Estimates on Higher Product Sales
Compared to Estimates, Incyte (INCY) Q1 Earnings: A Look at Key Metrics
Incyte taps Zimmer Biomet's Suketu Upadhyay as CFO
Incyte (INCY) Beats Q1 Earnings and Revenue Estimates
Earnings Scheduled For April 28, 2026
Incyte Non-GAAP EPS of $1.81 beats by $0.47, revenue of $1.26B beats by $50M
Here are the major earnings before the open Tuesday
Incyte Q1 2026 Earnings Preview
Incyte Gears Up to Report Q1 Earnings: What Can Investors Expect?
Incyte (INCY) Q4 2024 Earnings Transcript
Earnings Preview: Agios Pharmaceuticals (AGIO) Q1 Earnings Expected to Decline
31,459 Shares in Incyte Corporation $INCY Bought by CPC Advisors LLC
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
GraniteShares Advisors LLC Buys New Holdings in Incyte Corporation $INCY
Assetmark Inc. Raises Holdings in Incyte Corporation $INCY
AE Wealth Management LLC Purchases New Holdings in Incyte Corporation $INCY
Here's Why Incyte (INCY) is a Strong Value Stock
Merit Financial Group LLC Has $4.92 Million Stock Holdings in Incyte Corporation $INCY
Benchmark Financial LLC Invests $735,000 in Incyte Corporation $INCY
KBC Group NV Sells 157,700 Shares of Incyte Corporation $INCY
Do Options Traders Know Something About Incyte Stock We Don't?
Incyte Corporation $INCY Shares Purchased by Burney Co.
Beacon Harbor Wealth Advisors Inc. Takes Position in Incyte Corporation $INCY
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Perpetual Ltd Trims Stock Holdings in Incyte Corporation $INCY
Notable healthcare headlines for the week: Apellis, Centessa, and UnitedHealth in focus
Allspring Global Investments Holdings LLC Buys 112,736 Shares of Incyte Corporation $INCY
Trump may impose tariffs on drugmakers who haven't signed MFN deals - reports
Stocks hedge funds love
Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study
Top Quant rated undervalued large-cap stocks with high-growth grades
Diversified Trust Co. Has $1.40 Million Position in Incyte Corporation $INCY
KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data
Citi's large-cap stocks with negative ROE trends
Incyte Corporation $INCY Shares Sold by JPMorgan Chase & Co.
FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
Glenmede Investment Management LP Has $53.58 Million Stock Position in Incyte Corporation $INCY
Incyte (INCY) Down 4.2% Since Last Earnings Report: Can It Rebound?
The 20 stocks hedge funds love the most
US Bancorp DE Reduces Holdings in Incyte Corporation $INCY
INCY Wins EC Approval for Label Expansion of Oncology Drug Zynyz
Cathie Wood's weekly recap: adds to AMZN, BABA, HOOD, COIN, cuts TSM, BIDU
Incyte fails to win FDA label expansion for cancer therapy due to issues at Novo plant
American Century Companies Inc. Purchases 366,032 Shares of Incyte Corporation $INCY
Incyte Corporation $INCY Shares Bought by Fisher Asset Management LLC
Stock index futures stable after Wall Street selloff; eyes on key labor report
Focus Partners Advisor Solutions LLC Buys 8,581 Shares of Incyte Corporation $INCY
AustralianSuper Pty Ltd Purchases Shares of 213,241 Incyte Corporation $INCY
LLY Wins CHMP Nod for Olumiant's Expanded Use in Alopecia Areata
Andra AP fonden Boosts Stake in Incyte Corporation $INCY
Incyte to Present at Upcoming Investor Conferences
Cookson Peirce & Co. Inc. Acquires Shares of 11,331 Incyte Corporation $INCY
Incyte Q4 Earnings Call Highlights
Incyte: Why The Market Is Overreacting To A Guidance 'Miss'
Incyte Corporation (INCY) Q4 2025 Earnings Call Transcript
Incyte Corp (INCY) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Pipeline Advancements Amid Market Challenges
INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales
Incyte (INCY) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Incyte (INCY) Q4 Earnings Lag Estimates
Incyte weak 2026 revenue forecast heightens Jakafi patent concerns
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results
Profund Advisors LLC Sells 8,689 Shares of Incyte Corporation $INCY
Here's Why Incyte (INCY) is a Strong Value Stock
16,196 Shares in Incyte Corporation $INCY Bought by Azzad Asset Management Inc. ADV
Candriam S.C.A. Lowers Stock Holdings in Incyte Corporation $INCY
Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards?
Unveiling Incyte (INCY) Q4 Outlook: Wall Street Estimates for Key Metrics
4,901 Shares in Incyte Corporation $INCY Acquired by Optimize Financial Inc
Incyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Mirae Asset Global Investments Co. Ltd. Increases Stake in Incyte Corporation $INCY
Convergence Investment Partners LLC Grows Position in Incyte Corporation $INCY
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)
Hussman Strategic Advisors Inc. Has $2.67 Million Stock Position in Incyte Corporation $INCY
Incyte to Report Fourth Quarter and Year-End 2025 Financial Results
Here's Why Incyte (INCY) is a Strong Momentum Stock
Incyte Corporation $INCY Shares Purchased by Wealth Enhancement Advisory Services LLC
Why Incyte (INCY) is a Top Value Stock for the Long-Term
What Investors Should Know Before Buying Incyte
Donoghue Forlines LLC Invests $2.14 Million in Incyte Corporation $INCY
Incyte: Buy For The Turnaround, Stay For The Pipeline
Incyte's Pipeline Potential Signals Massive Upside For Investors
Incyte CEO Bill Meury: Blood cancer therapy development is company's central identity
Incyte Corporation (INCY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?
CoreCap Advisors LLC Purchases Shares of 4,743 Incyte Corporation $INCY
Mohamed Khairie Issa Sells 10,856 Shares of Incyte (NASDAQ:INCY) Stock
Incyte: Maintaining Buy Rating As Hem/Oncology Portfolio Adds 2 Recent Wins
INCY's Phase III Monjuvi Study Meets Key Goals in First-Line Lymphoma